Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds.
Macdonald, Jennifer A
Chen, John L
Holton, Janice L
Acta Neuropathol Commun
Springer Science and Business Media LLC
MetadataShow full item record
Macdonald, J. A., Chen, J. L., Masuda-Suzukake, M., Schweighauser, M., Jaunmuktane, Z., Warner, T., Holton, J. L., et al. (2021). Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds.. Acta Neuropathol Commun, 9 (1) https://doi.org/10.1186/s40478-021-01291-7
Peripheral administration (oral, intranasal, intraperitoneal, intravenous) of assembled A53T α-synuclein induced synucleinopathy in heterozygous mice transgenic for human mutant A53T α-synuclein (line M83). The same was the case when cerebellar extracts from a case of multiple system atrophy with type II α-synuclein filaments were administered intraperitoneally, intravenously or intramuscularly. We observed abundant immunoreactivity for pS129 α-synuclein in nerve cells and severe motor impairment, resulting in hindlimb paralysis and shortened lifespan. Filaments immunoreactive for pS129 α-synuclein were in evidence. A 70% loss of motor neurons was present five months after an intraperitoneal injection of assembled A53T α-synuclein or cerebellar extract with type II α-synuclein filaments from an individual with a neuropathologically confirmed diagnosis of multiple system atrophy. Microglial cells changed from a predominantly ramified to a dystrophic appearance. Taken together, these findings establish a close relationship between the formation of α-synuclein inclusions in nerve cells and neurodegeneration, accompanied by a shift in microglial cell morphology. Propagation of α-synuclein inclusions depended on the characteristics of both seeds and transgenically expressed protein.
Microglia, Multiple system atrophy, Neurodegeneration, Seeded assembly, α-Synuclein, Aged, Animals, Animals, Genetically Modified, Hindlimb, Humans, Immunohistochemistry, Male, Mice, Neurologic Mutants, Microglia, Motor Neurons, Movement Disorders, Multiple System Atrophy, Mutation, Neurodegenerative Diseases, Neurons, Paralysis, alpha-Synuclein
UK Medical Research Council (MC_U105184291)
External DOI: https://doi.org/10.1186/s40478-021-01291-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/332052
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org